Literature DB >> 17905609

Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin.

Erika V Valore1, Tomas Ganz.   

Abstract

Hepcidin is encoded as an 84 amino acid prepropeptide containing a typical N-terminal 24 amino acid endoplasmic reticulum targeting signal sequence, and a 35 amino acid proregion (pro) with a consensus furin cleavage site immediately followed by the C-terminal 25 amino acid bioactive iron-regulatory hormone (mature peptide). We performed pulse-chase studies of posttranslational processing of hepcidin in human hepatoma HepG2 cells and in primary human hepatocytes induced with bone morphogenic protein (BMP-9). In some experiments, the cells were treated with the furin protease inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone (CMK) or furin siRNA. In the absence of furin inhibitor, hepcidin was found to be processed in less than 1 h and secreted as a 3 kDa form reactive with anti-mature but not anti-pro antibody. In the presence of furin inhibitors or furin siRNA, a 6 kDa form reactive with both anti-pro and anti-mature antibody was rapidly secreted into the medium. Processing was not affected by inhibitors of the hypoxia inducible factor (HIF) pathway, or by treatment with 30 microM holo- or apo-transferrin. In conclusion, the hepatic prohormone convertase furin mediates the posttranslational processing of hepcidin. The proteolytic cleavage of prohepcidin to hepcidin is not regulated by iron-transferrin or the HIF pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905609      PMCID: PMC2211381          DOI: 10.1016/j.bcmd.2007.07.009

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  30 in total

1.  Serum pro-hepcidin and iron markers during uncomplicated pregnancy.

Authors:  Teresa Laskowska-Klita; Magdalena Chelchowska; Jadwiga Ambroszkiewicz; Ewa Swiatek; Jerzy Leibschang
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-05-08       Impact factor: 2.435

2.  Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System.

Authors:  Naohisa Tomosugi; Hiroshi Kawabata; Rumi Wakatabe; Masato Higuchi; Hideki Yamaya; Hisanori Umehara; Isao Ishikawa
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

3.  Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

Authors:  Erwin H J M Kemna; Harold Tjalsma; Vladimir N Podust; Dorine W Swinkels
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

4.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.

Authors:  Jaroslav Truksa; Hongfan Peng; Pauline Lee; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  Suppression of hepcidin during anemia requires erythropoietic activity.

Authors:  Mihwa Pak; Miguel A Lopez; Victroia Gabayan; Tomas Ganz; Seth Rivera
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

6.  Iron absorption by healthy women is not associated with either serum or urinary prohepcidin.

Authors:  Kevin B Hadley; LuAnn K Johnson; Janet R Hunt
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

7.  The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.

Authors:  Antonis Kattamis; Ioannis Papassotiriou; Danai Palaiologou; Filia Apostolakou; Angeliki Galani; Vassilis Ladis; Nikos Sakellaropoulos; George Papanikolaou
Journal:  Haematologica       Date:  2006-06       Impact factor: 9.941

8.  Hepcidin, a urinary antimicrobial peptide synthesized in the liver.

Authors:  C H Park; E V Valore; A J Waring; T Ganz
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

9.  A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.

Authors:  C Pigeon; G Ilyin; B Courselaud; P Leroyer; B Turlin; P Brissot; O Loréal
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

10.  Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.

Authors:  Mark A Roe; Caroline Spinks; Anne-Louise M Heath; Linda J Harvey; Rob Foxall; Jennie Wimperis; Christian Wolf; Susan J Fairweather-Tait
Journal:  Br J Nutr       Date:  2007-03       Impact factor: 3.718

View more
  66 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

2.  Molecular Characterisation of a Novel Isoform of Hepatic Antimicrobial Peptide, Hepcidin (Le-Hepc), from Leiognathus equulus and Analysis of Its Functional Properties In Silico.

Authors:  Aishwarya Nair; K S Sruthy; E R Chaithanya; T P Sajeevan; I S Bright Singh; Rosamma Philip
Journal:  Probiotics Antimicrob Proteins       Date:  2017-12       Impact factor: 4.609

Review 3.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

Review 4.  The liver: conductor of systemic iron balance.

Authors:  Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

Review 5.  The pathophysiology and pharmacology of hepcidin.

Authors:  Piotr Ruchala; Elizabeta Nemeth
Journal:  Trends Pharmacol Sci       Date:  2014-02-17       Impact factor: 14.819

6.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

Review 7.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

Review 8.  The role of hepcidin in iron metabolism.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

9.  A novel immunological assay for hepcidin quantification in human serum.

Authors:  Vasiliki Koliaraki; Martha Marinou; Theodoros P Vassilakopoulos; Eustathios Vavourakis; Emmanuel Tsochatzis; Gerassimos A Pangalis; George Papatheodoridis; Alexandra Stamoulakatou; Dorine W Swinkels; George Papanikolaou; Avgi Mamalaki
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

10.  Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.

Authors:  Elizabeta Nemeth
Journal:  Adv Hematol       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.